MELATONIN DECREASES OLANZAPINE INDUCED METABOLIC SIDE-EFFECTS IN ADOLESCENTS WITH BIPOLAR DISORDER: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOSTAFAVI ALI; SOLHI MAHMOUD; MOHAMMADI MOHAMMAD REZA; HAMEDI MEHDI; KESHAVARZI MARYAM; AKHONDZADEH SHAHIN

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ACTA MEDICA IRANICA Year:2014 | Volume:52 | Issue:10 Page(s): 734-739

Download Full-Text

View:

324

Download:

152

Cites:

Information Journal Paper

Title

MELATONIN DECREASES OLANZAPINE INDUCED METABOLIC SIDE-EFFECTS IN ADOLESCENTS WITH BIPOLAR DISORDER: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

Author(s)

Keywords

METABOLIC SYNDROME

OLANZAPINE

MELATONIN

BIPOLAR DISORDER

Abstract

Olanzapine is the frequently prescribed drug in children and adolescents with BIPOLAR DISORDER, but unfortunately it has metabolic side-effects. On the other hand, in a number of MELATONIN studies on sleep cycle, regulation of metabolic abnormalities has been reported. Therefore, we aimed to study effects of MELATONIN in reducing metabolic side-effects of OLANZAPINE in 11-17 year-old patients with BIPOLAR DISORDER. Seventy-seven 11-17 year-old outpatients entered into the study after their initial diagnosis of bipolar mood disorder by a psychiatrist. After assessing inclusion and exclusion criteria, 48 patients consented to participate in the study. Of this number, 24 patients were allocated to OLANZAPINE, lithium carbonate, and MELATONIN and 24 patients were allocated to OLANZAPINE, lithium carbonate, and placebo. Young mania rating scale was performed at baseline. Before treatment initiation and at sixth and twelfth weeks after treatment, Lipid profile, Fasting Blood Sugar (FBS), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) were measured. ANOVA with repeated measure and independent sample t-test were used for data analysis. Nineteen patients in each group completed the study and yielded data for analysis. ANOVA with repeated measure showed that FBS and Triglyceride (TG) (especially in boys) demonstrated greater increase in the placebo group compared to the MELATONIN group but the differences were not statistically significant.Melatonin significantly inhibited the rise in Total Cholesterol levels compared to placebo (P=0.032). Mean SBP rose more slowly in the MELATONIN group (1.05mmHg) compared to placebo (6.36 mmHg) (P=0.023). The trends in DBP did not show any significant pattern. Administration of MELATONIN along with OLANZAPINE and lithium carbonate could significantly inhibit the rise in cholesterol level and SBP compared to placebo. The effect of MELATONIN on TG was more obvious in boys. MELATONIN was more effective in prevention of SBP rise.

Cites

No record.

References

Cite

APA: Copy

MOSTAFAVI, ALI, SOLHI, MAHMOUD, MOHAMMADI, MOHAMMAD REZA, HAMEDI, MEHDI, KESHAVARZI, MARYAM, & AKHONDZADEH, SHAHIN. (2014). MELATONIN DECREASES OLANZAPINE INDUCED METABOLIC SIDE-EFFECTS IN ADOLESCENTS WITH BIPOLAR DISORDER: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL. ACTA MEDICA IRANICA, 52(10), 734-739. SID. https://sid.ir/paper/278611/en

Vancouver: Copy

MOSTAFAVI ALI, SOLHI MAHMOUD, MOHAMMADI MOHAMMAD REZA, HAMEDI MEHDI, KESHAVARZI MARYAM, AKHONDZADEH SHAHIN. MELATONIN DECREASES OLANZAPINE INDUCED METABOLIC SIDE-EFFECTS IN ADOLESCENTS WITH BIPOLAR DISORDER: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL. ACTA MEDICA IRANICA[Internet]. 2014;52(10):734-739. Available from: https://sid.ir/paper/278611/en

IEEE: Copy

ALI MOSTAFAVI, MAHMOUD SOLHI, MOHAMMAD REZA MOHAMMADI, MEHDI HAMEDI, MARYAM KESHAVARZI, and SHAHIN AKHONDZADEH, “MELATONIN DECREASES OLANZAPINE INDUCED METABOLIC SIDE-EFFECTS IN ADOLESCENTS WITH BIPOLAR DISORDER: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL,” ACTA MEDICA IRANICA, vol. 52, no. 10, pp. 734–739, 2014, [Online]. Available: https://sid.ir/paper/278611/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops